Mao‐xu Ge

442 total citations
15 papers, 357 citations indexed

About

Mao‐xu Ge is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Mao‐xu Ge has authored 15 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hepatology, 7 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in Mao‐xu Ge's work include Liver physiology and pathology (9 papers), Liver Disease Diagnosis and Treatment (7 papers) and Drug Transport and Resistance Mechanisms (3 papers). Mao‐xu Ge is often cited by papers focused on Liver physiology and pathology (9 papers), Liver Disease Diagnosis and Treatment (7 papers) and Drug Transport and Resistance Mechanisms (3 papers). Mao‐xu Ge collaborates with scholars based in China and United States. Mao‐xu Ge's co-authors include Hongwei He, Rong‐Guang Shao, Yixuan Zhang, Yong‐Zhan Zhen, Shi‐Ying Cai, Wuli Zhao, Dongke Yu, James L. Boyer, Hong Liu and Xinshou Ouyang and has published in prestigious journals such as British Journal of Pharmacology, Molecules and Biochemical Pharmacology.

In The Last Decade

Mao‐xu Ge

15 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mao‐xu Ge China	11	157	133	123	66	58	15	357
Chaoliang Ge China	8	171 1.1×	90 0.7×	122 1.0×	102 1.5×	49 0.8×	12	323
Xuguang Zhai China	12	203 1.3×	162 1.2×	139 1.1×	27 0.4×	37 0.6×	25	405
Bert Van Den Bossche Belgium	5	266 1.7×	133 1.0×	201 1.6×	37 0.6×	53 0.9×	10	470
Lungen Lu China	11	138 0.9×	92 0.7×	126 1.0×	53 0.8×	26 0.4×	27	315
Sidong Song China	10	95 0.6×	80 0.6×	86 0.7×	74 1.1×	69 1.2×	11	352
Hailing Liu China	9	238 1.5×	145 1.1×	165 1.3×	56 0.8×	62 1.1×	23	510
Hongying Gan‐Schreier Germany	14	152 1.0×	194 1.5×	56 0.5×	47 0.7×	27 0.5×	28	485
Manon Homan Netherlands	4	166 1.1×	166 1.2×	130 1.1×	131 2.0×	65 1.1×	5	423
Justin D. Schumacher United States	9	227 1.4×	169 1.3×	106 0.9×	124 1.9×	38 0.7×	10	415

Countries citing papers authored by Mao‐xu Ge

Since Specialization

Citations

This map shows the geographic impact of Mao‐xu Ge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mao‐xu Ge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mao‐xu Ge more than expected).

Fields of papers citing papers by Mao‐xu Ge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mao‐xu Ge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mao‐xu Ge. The network helps show where Mao‐xu Ge may publish in the future.

Co-authorship network of co-authors of Mao‐xu Ge

This figure shows the co-authorship network connecting the top 25 collaborators of Mao‐xu Ge. A scholar is included among the top collaborators of Mao‐xu Ge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mao‐xu Ge. Mao‐xu Ge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Ge, Mao‐xu, et al.. (2023). Sclareol attenuates liver fibrosis through SENP1‐mediated VEGFR2 SUMOylation and inhibition of downstream STAT3 signaling. Phytotherapy Research. 37(9). 3898–3912. 8 indexed citations

Zhang, Qian, Yuzhuo Wu, Mao‐xu Ge, et al.. (2022). Paeoniflorin-free subfraction of Paeonia lactiflora Pall. shows the potential of anti-hepatic fibrosis: an integrated analysis of network pharmacology and experimental validation. Journal of Ethnopharmacology. 299. 115678–115678. 12 indexed citations

Zhang, Na, Mao‐xu Ge, Yiming Li, et al.. (2022). Dehydromevalonolactone ameliorates liver fibrosis and inflammation by repressing activation of NLRP3 inflammasome. Bioorganic Chemistry. 127. 105971–105971. 15 indexed citations

Ge, Mao‐xu, et al.. (2022). Tripartite motif-containing 25 facilitates immunosuppression and inhibits apoptosis of glioma via activating NF-κB. Experimental Biology and Medicine. 247(17). 1529–1541. 7 indexed citations

Ge, Mao‐xu, et al.. (2021). Pantoprazole ameliorates liver fibrosis and suppresses hepatic stellate cell activation in bile duct ligation rats by promoting YAP degradation. Acta Pharmacologica Sinica. 42(11). 1808–1820. 30 indexed citations

Fan, Tianyun, Mao‐xu Ge, Zhihao Guo, et al.. (2020). Discovery of 9O-Substituted Palmatine Derivatives as a New Class of Anti-COL1A1 Agents Via Repressing TGF-β1/Smads and JAK1/STAT3 Pathways. Molecules. 25(4). 773–773. 11 indexed citations

Ge, Mao‐xu, Rong‐Guang Shao, & Hongwei He. (2019). Advances in understanding the regulatory mechanism of cholesterol 7α-hydroxylase. Biochemical Pharmacology. 164. 152–164. 31 indexed citations

Cai, Shi‐Ying, Mao‐xu Ge, Albert Mennone, et al.. (2019). Inflammasome Is Activated in the Liver of Cholestatic Patients and Aggravates Hepatic Injury in Bile Duct–Ligated Mouse. Cellular and Molecular Gastroenterology and Hepatology. 9(4). 679–688. 38 indexed citations

Ge, Mao‐xu, et al.. (2019). Costunolide represses hepatic fibrosis through WW domain‐containing protein 2‐mediated Notch3 degradation. British Journal of Pharmacology. 177(2). 372–387. 46 indexed citations

10.

Ge, Mao‐xu, Jinfeng Ren, Shi‐Ying Cai, et al.. (2018). A novel ASBT inhibitor, IMB17-15, repressed nonalcoholic fatty liver disease development in high-fat diet-fed Syrian golden hamsters. Acta Pharmacologica Sinica. 40(7). 895–907. 32 indexed citations

11.

Zhao, Shuangshuang, Wuli Zhao, Mao‐xu Ge, et al.. (2017). D-chiro-inositol effectively attenuates cholestasis in bile duct ligated rats by improving bile acid secretion and attenuating oxidative stress. Acta Pharmacologica Sinica. 39(2). 213–221. 24 indexed citations

12.

Ge, Mao‐xu, Hong Liu, Yixuan Zhang, et al.. (2017). The anti‐hepatic fibrosis effects of dihydrotanshinone I are mediated by disrupting the yes‐associated protein and transcriptional enhancer factor D2 complex and stimulating autophagy. British Journal of Pharmacology. 174(10). 1147–1160. 59 indexed citations

13.

Ge, Mao‐xu, Hongwei He, Rong‐Guang Shao, & Hong Liu. (2017). Recent progression in the utilization of autophagy-regulating nature compound as anti-liver fibrosis agents. Journal of Asian Natural Products Research. 19(2). 109–113. 7 indexed citations

14.

Ge, Mao‐xu, Juxian Wang, Rong‐Guang Shao, & Hongwei He. (2017). [Advances in studies of ileal apical sodium-dependent bile acid transporter].. PubMed. 52(2). 189–97. 5 indexed citations

15.

Zhao, Shuangshuang, Yong‐Zhan Zhen, Mao‐xu Ge, et al.. (2015). Protective effect of gastrodin on bile duct ligation-induced hepatic fibrosis in rats. Food and Chemical Toxicology. 86. 202–207. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact